Executive Chairman Wei Fu Completes Over $5M Share Purchase, Confirming Prior Intent

summarizeSummary

Executive Chairman Wei Fu and affiliated entities have completed the purchase of approximately $5.1 million worth of NovaBridge Biosciences ADSs, confirming his previously announced intention to invest in the company.

check_boxKey Events

• Executive Chairman Completes $5.1M Share Purchase

  Executive Chairman Wei Fu and affiliated entities acquired approximately $5.1 million worth of NovaBridge Biosciences ADSs through open market transactions.

• Confirms Prior Investment Intent

  This filing finalizes the previously announced intention by Mr. Fu on January 16, 2026, to purchase up to $5 million in shares, providing concrete details of the execution.

• Increased Beneficial Ownership

  The purchases contribute to Mr. Fu's beneficial ownership, which now stands at 11.5% of the outstanding ordinary shares.

• Purchases Above Current Market Price

  The ADSs were bought in open market transactions between January 15 and January 29, 2026, at an average price of approximately $3.90 per ADS, which is a premium to the current stock price.

auto_awesomeAnalysis

This Schedule 13D/A confirms the completion of a substantial insider purchase by Executive Chairman Wei Fu and his affiliated investment entities. The acquisition of approximately $5.1 million in NovaBridge Biosciences ADSs, representing about 1.29% of the company's market capitalization, signals strong conviction from a key executive. This transaction finalizes the intention Mr. Fu announced on January 16, 2026, to invest up to $5 million, following the positive Phase 1b data reported on January 6, 2026. The open market purchases, executed at an average price of approximately $3.90 per ADS, which is higher than the current stock price of $3.48, further underscore the Chairman's confidence in the company's future.